Cannex Therapeutics LLC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Cannex Therapeutics LLC

Sort by

Viewing results 1‒25 of 32

LexTechnology sector
Tech stocks: 13F disclosures unlock sector secrets Premium content
...Many are medtech or biotech companies, including Decibel Therapeutics and Fulcrum Therapeutics. Google dissolved healthcare unit Google Health in 2021....
October 19, 2023
On Wall StreetSujeet Indap
Junior analyst’s lawsuit against top bank puts Wall Street hours on trial
...That day she told the firm’s human resources department about her medical condition and a therapeutic need to get eight to nine hours of sleep a night, later confirmed by a nurse’s note....
November 18, 2023
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
LexMergers & Acquisitions
Pharma: M&A strategy gets dose of bitter medicine Premium content
...Monday’s acquisition by Novartis of Seattle-based biotech firm Chinook Therapeutics for up to $3.5bn is a case in point....
June 12, 2023
ETF HubLatest news on ETFs
Tesla champion Ark Investment outguns Wall Street titans
...Its flagship fund, the Innovation ETF, which is dominated by holdings in electric car maker Tesla, streaming company Roku and biotech Crispr Therapeutics, appreciated by 150 per cent last year....
February 1, 2021
The Top LineDavid Crow
Cathie Wood’s breathless promotion of gene editing should worry us all
...She is also a cheerleader for this emerging field of medical science, telling CNBC in December that three listed companies in the space — Intellia, Crispr Therapeutics and Editas — represent a “trillion...
February 18, 2022
FT Alphaville
How to spend a million dollars, by Sam Bankman-Fried
...Zhao declined to comment. 12) Telis Bioscience ($1mn for 2pc) CEO Grigory Khimulya says Telis Bioscience is “a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics...
December 19, 2022
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
#techFT
Mobile’s quieter 5G networking
...Meanwhile, US start-up Intellia Therapeutics has successfully treated the first patients using a Crispr gene-editing therapy directed inside the body to an internal organ — a breakthrough, with the technology...
June 28, 2021
Bristol-Myers Squibb Co
Bristol-Myers wins backing of big advisers on $90bn Celgene deal
...The Celgene takeover is the largest of several significant pharma and healthcare deals in the first quarter, with others including Roche’s $4.8bn purchase of gene therapy company Spark Therapeutics and Johnson...
March 29, 2019
Capital markets
Little-known Chicago fund wins big in US IPO bonanza
...For one, shares in Menlo Therapeutics, a pharmaceutical company making treatments for itchy skin and coughs, are down 53 per cent from their offer price after its drug serlopitant underperformed in one of...
August 24, 2018
News in-depthAsset allocation
Are you following the wrong small-cap index?
...In one quirk, a move by S&P Dow Jones Indices to promote biotech company Nektar Therapeutics from the S&P 600 to the S&P 500 in mid-March has also had an effect on the indices’ relative performance....
June 8, 2018
fastFTMatthew Vincent
Opening Quote: Unilever seeks a deep clean of the internet
...Shield Therapeutics’ prospects were supposed to be pretty much iron clad. But the Aim-quoted biopharma business developing treatments for anaemia couldn’t shield investors last week....
February 12, 2018
Brexit
Fast Europe Open: UK retail sales, South Africa CPI
...Corporate earnings and updates for Wednesday include Kingfisher, Cambian Group, Cenkos Securities and Shield Therapeutics....
September 20, 2017
World
Sanofi poaches immunology expert from AstraZeneca
...His world-class experience in immunology, oncology and translational medicine will be vital assets as Sanofi sets its sights on scientific excellence and innovation across its therapeutic areas....
March 29, 2016
FT AlphavilleMergers & Acquisitions
Shkreli’s new target market: 1100 Americans-a-year
...At this stage of a new drug’s life there’s presumed to be no evidence that it has any therapeutic value whatsoever. Nevertheless, KaloBios is now valued at circa $150m....
November 24, 2015
US & Canadian companies
Bill Gates joins $120m fundraising for Editas Medicine gene start-up
...Intellia Therapeutics raised $15m last year before signing a collaboration with Novartis in January....
August 10, 2015
FT Live
Transforming the Finance Function with AI
Strategies for delivering advanced analytics, automation and decision-making
Thursday, 25 AprilDigital Conference
IPOs
Confetti and bells herald US equity listings
...The move was the third-largest opening “pop” this year behind the debuts of Shake Shack and Spark Therapeutics, according to Dealogic....
April 16, 2015
US & Canadian companies
Google-backed genetic testing company hires veteran scientist
..., which claims to have built the world’s biggest database of human genetic data through its $99 DNA saliva test, said that Richard Scheller would join as chief science officer to lead the company’s new therapeutics...
March 12, 2015
Tech blogHannah Kuchler
Amazon’s Bezos looks out for investment opportunities
...Health: The Amazon founder has participated in two fundraising rounds in Juno Therapeutics, a company which is developing immunotherapies for the treatment of cancer....
August 13, 2014
Gold
Intercept surges on liver treatment trial
...“The fibrosis benefit with OCA treatment is the first time we are aware of that a therapeutic has been shown to significantly improve liver fibrosis in a meaningful proportion of NASH patients, an unexpected...
August 12, 2014
Pharmaceuticals sector
AstraZeneca experiments with Spirogen deal
...It will also pay $20m to take an equity stake in ADC Therapeutics, a Swiss based cancer drug developer....
October 15, 2013
Business education
Alibaba boss sees benefits of risk taking
...I find different types of exercise, usually outside, very therapeutic. And reading – especially about China....
October 9, 2013
US & Canadian companies
Elan steps up fight against Royalty Pharma bid
...The company also plans to spend up to $78m for an 18 per cent stake in Speranza Therapeutics, a spin-off company with an experimental drug for Alzheimer’s disease, while issuing new debt for $800m....
May 20, 2013
beyondbricsMergers & Acquisitions
Venture capital spurs Russian drug development – in California
...The deal that will give Rusnano a minority stake in Coda Therapeutics has obvious beneﬁts for Domain, drawing a heavyweight Russian investor into one of its existing portfolio companies....
July 25, 2012
FT AlphavilleMergers & Acquisitions
Cohen’s SAC Capital faces insider trading probe
...SAC’s bets on stocks including United Therapeutics Corp, Genentech Inc. and ViroPharma Inc attracted Finra’s attention because they were made before market-moving events, such as acquisitions and the release...
October 25, 2011
US & Canadian companies
Buy-out groups in $3.9bn deal to acquire PPD
...Karen Bechtel, managing director and head of Carlyle’s healthcare group, said the buy-out firm would help to expand PPD’s therapeutic expertise....
October 3, 2011

Previous pagePage 1 of 2Next page